In-Person Registration for Industry Professionals | Expert Second Opinion: Investigators Provide Perspectives on the Future Role of AKT Inhibition in the Management of Prostate Cancer
Submissions for this form are closed.
This activity is intended for medical and radiation oncologists, urologists and other healthcare providers involved in the treatment of prostate cancer.